SELECTING A SUITABLE DRUG FOR THE HYPERLIPIDAEMIC PATIENT Newsletter Article 14 February 2013 Pages: 2 - 2
IBUPROFEN AVAILABLE FOR OVER-THE-COUNTER SALES BY PHARMACISTS IN UK Newsletter Article 14 February 2013 Pages: 2 - 2
MIANSERIN IN THE ELDERLY: SLOWER CLEARANCE BUT PERHAPS LESS SEDATION Newsletter Article 14 February 2013 Pages: 2 - 2
THE SEARCH FOR SHORT-COURSE ANTITUBERCULOSIS REGIMENS CONTINUES Newsletter Article 14 February 2013 Pages: 3 - 3
FILM-COATED ASPIRIN IS EASIER TO SWALLOW AND CAUSES FEWER SIDE EFFECTS Newsletter Article 14 February 2013 Pages: 4 - 5
AT THE FOREFRONT OF INVESTIGATION OF ANTI-INFECTIVES Newsletter Article 14 February 2013 Pages: 5 - 6
LEUCOCYTE INTERFERON: treatment of carcinoid tumours Newsletter Article 14 February 2013 Pages: 6 - 6
CARBAMAZEPINE AND PHENYTOIN BOTH CONTROL EPILEPTIC SEIZURES Newsletter Article 14 February 2013 Pages: 7 - 8
HIGHER DOSE/LOWER FREQUENCY PARENTERAL GOLD INDUCTION THERAPY FOR RA? Newsletter Article 14 February 2013 Pages: 8 - 8
GEMFIBROZIL PROVIDES BENEFICIAL LIPID CHANGES IN HYPERLIPIDAEMIC PATIENTS Newsletter Article 14 February 2013 Pages: 8 - 9
PIVMECILLINAM + PIVAMPICILLIN EFFECTIVELY TREATS CHRONIC BRONCHITIS Newsletter Article 14 February 2013 Pages: 9 - 9
A SUCCESSFUL PREGNANCY IS REPORTED FOLLOWING CYCLOSPORIN TREATMENT Newsletter Article 14 February 2013 Pages: 9 - 9
FOCUS ON SOME OF THE BENZODIAZEPINE HYPNOTICS AND ANXIOLYTICS Newsletter Article 14 February 2013 Pages: 10 - 11
AMOEBIC LIVER ABSCESS CLEARED BY A ONE-DAY DOSE OF IMIDAZOLE DERIVATIVES Newsletter Article 14 February 2013 Pages: 12 - 12
DIHYDROERGOCRISTINE: AN ERGOT DERIVATIVE WITH RELATIVELY FEW SIDE EFFECTS Newsletter Article 14 February 2013 Pages: 12 - 12
NADOLOL REDUCES ESSENTIAL TREMOR IN SIX PROPRANOLOL RESPONDERS Newsletter Article 14 February 2013 Pages: 12 - 12
TWO STUDIES CAST DOUBT ON THE NEED TO GIVE METHYLPHENIDATE BEFORE FOOD Newsletter Article 14 February 2013 Pages: 12 - 13
THE DISPOSITION OF ORAL QUINIDINE IS ALTERED BY CIMETIDINE Newsletter Article 14 February 2013 Pages: 13 - 13
ISOXICAM: PHARMACOKINETICS AFTER ORAL AND RECTAL ADMINISTRATION Newsletter Article 14 February 2013 Pages: 13 - 13
TREATING THE UNBORN AND NEWBORN WITH CEPHALOSPORINS Newsletter Article 14 February 2013 Pages: 14 - 14
HIGH DOSE KETOPROFEN INHIBITS IN VITRO PLATELET AGGREGATION Newsletter Article 14 February 2013 Pages: 14 - 14
SERUM DIGOXIN LEVELS MAY INCREASE DURING PREGNANCY Newsletter Article 14 February 2013 Pages: 15 - 15
AMINOGLYCOSIDE PHARMACOKINETICS PROVIDE SOME DOSE RECOMMENDATIONS Newsletter Article 14 February 2013 Pages: 15 - 15
TOCAINIDE: AN UPBEAT LIGNOCAINE DERIVATIVE FOR VENTRICULAR ARRHYTHMIAS Newsletter Article 14 February 2013 Pages: 16 - 17
THE STORY SO FAR ON Δ-9-TETRAHYDROCANNABINOL HAS BEEN HIGHLY CONFUSING Newsletter Article 14 February 2013 Pages: 17 - 18
EPOPROSTENOL (prostacyclin; PGI2; U-53,217): prostaglandin platelet aggregation inhibitor now introduced in the UK by Wellcome (‘Flolan’) and Upjohn (‘Cyclo-Prostin’) - a world first introduction Newsletter Article 14 February 2013 Pages: 19 - 20